November 8, 2018Open Access

Interest of Youth Living With HIV in Long-Acting Antiretrovirals

Key Points

Key points are not available for this paper at this time.

Abstract

YHIV at 4 urban US pediatric/adolescent HIV clinics had high levels of enthusiasm for LAARV. LAARV should be given high priority as a potentially viable treatment option to improve clinical outcomes in YHIV.

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Weld et al. (Thu,) studied this question.

synapsesocial.com/papers/69d80ab505ee2ba81dbeecc6 https://doi.org/https://doi.org/10.1097/qai.0000000000001896

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The importance of choice in the rollout of ARV‐based prevention to user groups in Kenya and South Africa: a qualitative study2014 · 76 citations
2Diagnoses of HIV infection in the United States and dependent areas, 20122014 · 430 citations
3The promise and pitfalls of long-acting injectable agents for HIV prevention2015 · 111 citations
4Marijuana Use and Its Association With Adherence to Antiretroviral Therapy Among HIV-Infected Persons With Moderate to Severe Nausea2004 · 93 citations
5Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.2016 · 110 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper